UPDATE: MKM Partners Upgrades Infinera Corporation (INFN) to Buy
Tweet Send to a Friend
(Updated - February 4, 2013 9:27 AM EST)
(correction) MKM Partners upgraded Infinera Corporation (INFN) from Neutral to Buy.
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $34.12 yesterday, with a 52 week range of $5.96-$37.42.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
(correction) MKM Partners upgraded Infinera Corporation (INFN) from Neutral to Buy.
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $34.12 yesterday, with a 52 week range of $5.96-$37.42.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
- Lazard Raises PT on Chicago Bridge & Iron (CBI) to $75
- JPMorgan Upgrades People's United Financial (PBCT) to Overweight
Create E-mail Alert Related Categories
Upgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
